Searched for
ARAGEN BIOLOGICS
Goldman-backed Aragen eyes Rs 12,000 crore as pre-IPO dose; Novo Nordisk keenInvestors including Quadria Capital and Denmark-based pharmaceutical major Novo Nordisk are among those interested in a minority stake and ...
Indian drug manufacturers benefit from Big Pharma interest beyond ChinaChina has for nearly 20 years been the preferred location for a range of pharmaceutical research and manufacturing services due to the low ...
Aragen acquires Pune-based pre-clinical research provider IntoxAragen Life Sciences signs a definitive agreement to acquire Pune-based Intox Pvt. Ltd. The Hyderabad-based Aragen, which was formerly call...
Goldman Sachs buys stake in contract research firm Aragen Life SciencesAragen is a leading provider of outsourced discovery, development, and manufacturing services across both large and small molecule platform...
Goldman Sachs set to buy 33% stake in GVK Bio at Rs 7,300-crore valuationThe other contenders included Carlyle Group, Warburg Pincus, General Atlantic and Quadria Capital, as well as Singapore’s Temasek Holdings.
Global PE funds eye stake in GVK Bio, co valued at $800 mnIn this proposed transaction, GVK BIO- promoted by the GVK Group and DS Brar, the former CEO and managing director of Ranbaxy Laboratories,...
GVK Biosciences plans Rs 100 crore active pharmaceutical ingredients facilityGVK Biosciences proposes to set up active pharmaceutical ingredients (APIs) manufacturing facility to cater to the needs of its existing an...
GVK BIO signs pact with US-based Aragen Bioscience Inc for acquisitionGVK BIO, a leading small-molecule Contract Research Organisation (CRO) today announced that it signed an agreement to acquire Aragen Biosci...